PAT-SM6

N/A

Report date: 2022/07/20 10:11:25

Base Information

Drug NamePAT-SM6
Drug Alias NameSM6PAT-SM6
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionLow-density lipoprotein modulators78 kDa glucose-regulated protein inhibitors
TargetsLow-density lipoprotein78 kDa glucose-regulated protein
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOncomab Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPatrys Ltd
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A